Loading…
Adenoviral gene transfer in a rat fracture model
For the enhancement of fracture healing, either purified proteins or vectors for expression of growth factors in situ may be used. Adenoviral vectors directly convert cells to express a transgene. However, the cell types which are preferentially infected and the time of expression during fracture he...
Saved in:
Published in: | Laboratory animals (London) 2002-10, Vol.36 (4), p.455-461 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | For the enhancement of fracture healing, either purified proteins or vectors for
expression of growth factors in situ may be used. Adenoviral vectors
directly convert cells to express a transgene. However, the cell types which are
preferentially infected and the time of expression during fracture healing are
currently not known. The adenoviral type 5 vectors used in this study are replication
incompetent viruses, one encoding β-galactosidase (β-GAL) and one green fluorescent
protein. Femora of 35 Sprague-Dawley rats were fractured. Three days after
stabilization with Kirschner wire, 1012 pfu viral suspension were injected
into the fracture zone. As a control, five animals received injections of adenovirus
type 2. Animals were sacrificed after 3 days, 1, 2 and 4 weeks. Fractures healed
radiographically within 2-3 weeks. All specimens were examined for β-GAL and green
fluorescent protein (GFP) expression. Fibroblast and osteoblasts within callus tissue
displayed a high transgene expression (week 1). A decrease of expression was observed
during the observation period. In this experimental study, we have demonstrated that
all cells of the primary callus can be transfected using adenoviral vectors, which
provide a tool to further investigate adenoviral transfer of growth factors such as
bone morphogenetic protein-2 (BMP-2). |
---|---|
ISSN: | 0023-6772 1758-1117 |
DOI: | 10.1258/002367702320389134 |